# A Phase 1 Study of PTX-35 in Healthy Volunteers

> **NCT05116969** · PHASE1 · WITHDRAWN · sponsor: **Heat Biologics**

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** PTX-35

## Key facts

- **NCT ID:** NCT05116969
- **Lead sponsor:** Heat Biologics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-11-24
- **Primary completion:** 2022-11-29
- **Final completion:** 2022-11-29
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor withdrew submission to Human Research Ethics Committee as it evaluates the need for healthy volunteer data for development plan.
- **Last updated:** 2022-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05116969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05116969, "A Phase 1 Study of PTX-35 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05116969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*